Logo of Huzzle
Logo of EyePoint Pharmaceuticals
Logo of EyePoint Pharmaceuticals

EyePoint Pharmaceuticals

Watertown, MAWebsite
Delivering Innovation to the Eye™ NOW HIRING!

👩‍💼

51-200

Employees

🏭

Science & Healthcare

Industry

Mission & purpose

EyePoint Pharmaceuticals (Nasdaq: EYPT) is a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The Company's pipeline leverages its proprietary Durasert® technology for sustained intraocular drug delivery including EYP-1901, a potential six-month intravitreal anti-VEGF treatment initially targeting wet age-related macular degeneration. Durasert’s proven intravitreal drug delivery platform has been safely administered to thousands of patients' eyes across four U.S. FDA-approved products, including YUTIQ® for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye, which is currently marketed by the Company. EyePoint Pharmaceuticals is headquartered in Watertown, Massachusetts.